AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 279: E1216-E1225, 2000;
0193-1849/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coss, D.
Right arrow Articles by Walker, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coss, D.
Right arrow Articles by Walker, A. M.
Vol. 279, Issue 6, E1216-E1225, December 2000

Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat

Djurdjica Coss, Lili Yang, Chiaoyun Benson Kuo, Xiaolei Xu, Richard A. Luben, and Ameae M. Walker

Division of Biomedical Sciences, University of California, Riverside, California 92521

The purpose of the current study was to determine whether maternal prolactin (PRL) had any effects on bone formation in the developing rat pup. Because the most prevalent forms of PRL in rats are unmodified and phosphorylated PRL, both recombinant PRL and a molecular mimic of phosphorylated PRL (PP-PRL) were administered to pregnant animals. Blood samples from the dams showed normal estrogen and progesterone and no effect of extra PRL on parathyroid hormone (PTH), calcium, or alkaline phosphatase (AP). In newborn pups, however, there was a 30% decrease in blood AP in both PRL-treated groups, whereas PTH and calcium levels were not different from controls. When primary rat osteoblasts were exposed to both PRLs, AP activity was reduced, with PP-PRL being the more potent form of the hormone. Histological examination of pup bone formation showed reduced calvarial bone and reduced endochondral ossification in pups exposed to PP-PRL. These results are the first to show a direct inhibitory effect of PRL on osteoblast function.

phosphorylated prolactin; intramembranous bone formation; endochondral bone formation


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
M K. Javaid and R. I. Holt
Understanding osteoporosis
J Psychopharmacol, March 1, 2008; 22(2_suppl): 38 - 45.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
V. L. Williams, A. DeGuzman, H. Dang, M. Kawaminami, T. W. C. Ho, D. G. Carter, and A. M. Walker
Common and specific effects of the two major forms of prolactin in the rat testis
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1795 - E1803.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. C. Horner, Y. Cazals, R. Guieu, M. Lenoir, and N. Sauze
Experimental estrogen-induced hyperprolactinemia results in bone-related hearing loss in the guinea pig
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1224 - E1232.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. Charoenphandhu, K. Tudpor, K. Thongchote, W. Saengamnart, S. Puntheeranurak, and N. Krishnamra
High-calcium diet modulates effects of long-term prolactin exposure on the cortical bone calcium content in ovariectomized rats
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E443 - E452.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C Zermeno, J Guzman-Morales, Y Macotela, G Nava, F Lopez-Barrera, J B Kouri, C Lavalle, G M. de la Escalera, and C Clapp
Prolactin inhibits the apoptosis of chondrocytes induced by serum starvation.
J. Endocrinol., May 1, 2006; 189(2): R1 - R8.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
I. Shur, R. Solomon, and D. Benayahu
Dynamic Interactions of Chromatin-Related Mesenchymal Modulator, a Chromodomain Helicase-DNA-Binding Protein, with Promoters in Osteoprogenitors.
Stem Cells, May 1, 2006; 24(5): 1288 - 1293.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online